[1] Jo VY, Fletcher CDM.  WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition[J]. Pathology, 2014, 46(2): 95-104.   doi: 10.1097/PAT.0000000000000050
[2] 朱艳, 刘兰, 张瑜, 等.  原发性骨淋巴瘤的18F-FDG PET/CT显像特点分析[J]. 中国医学影像学杂志, 2017, 25(2): 116-120.   doi: 10.3969/j.issn.1005-5185.2017.02.010
Zhu Y, Liu L, Zhang Y, et al.  Features of 18F-FDG PET/CT imaging of primary lymphoma of bone[J]. Chin J Med Imaging, 2017, 25(2): 116-120.   doi: 10.3969/j.issn.1005-5185.2017.02.010
[3] 吴枕戈, 郑汉朋, 邱乾德.  原发性骨淋巴瘤影像表现[J]. 中国临床医学影像杂志, 2016, 27(6): 431-434.
Wu ZG, Zheng HP, Qiu QD.  Imaging finding of primary bone lymphoma[J]. J China Clin Med Imaging, 2016, 27(6): 431-434.
[4] Liu YY.  The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma[J]. Nucl Med Commun, 2017, 38(4): 319-324.   doi: 10.1097/MNM.0000000000000652
[5] 郭锐, 李囡, 方志伟, 等.  18F-FDG PET/CT在骨破坏鉴别诊断中的应用[J]. 中华肿瘤防治杂志, 2018, 25(8): 581-585.   doi: 10.16073/j.cnki.cjcpt.2018.08.011
Guo R, Li N, Fang ZW, et al.  Value of 18F-FDG-PET/CT in patients with synchronous multiple primary carcinomas[J]. Chin J Cancer Prev Treat, 2018, 25(8): 581-585.   doi: 10.16073/j.cnki.cjcpt.2018.08.011
[6] 吴新武, 陈顺有.  儿童原发性骨淋巴瘤2例报告并文献复习[J]. 中外医学研究, 2020, 18(23): 186-188.   doi: 10.14033/j.cnki.cfmr.2020.23.074
Wu XW, Chen SY.  A report of 2 cases with primary bone lymphoma of children and literature review[J]. Chin Foreign Med Res, 2020, 18(23): 186-188.   doi: 10.14033/j.cnki.cfmr.2020.23.074
[7] Thornton E, Krajewski KM, O'regan KN, et al.  Imaging features of primary and secondary malignant tumours of the sacrum[J]. Br J Radiol, 2012, 85(1011): 279-286.   doi: 10.1259/bjr/25247602
[8] 杨东, 安立龙, 孙满顿, 等.  原发性骨淋巴瘤的影像诊断及误诊分析[J]. 医学影像学杂志, 2017, 27(8): 1550-1553.
Yang D, An LL, Sun MD, et al.  The analysis on imageology dignosis and misdiagnosis for primary lymphoma of bone[J]. J Med Imaging, 2017, 27(8): 1550-1553.
[9] 刘子君, 文剑明.  骨原发性非何杰金氏恶性淋巴瘤的病理[J]. 中华肿瘤杂志, 1986, (5): 352-354.
Liu ZJ, Wen JM.  Pathology of primary non-Hodgkin's malignant lymphoma of bone[J]. Chin J Oncol, 1986, (5): 352-354.
[10] 孙悦, 许宏, 郭振清, 等.  探索18F-FDG PET/CT SUVmax、SUVsum及病理Ki67表达等在非霍奇金淋巴瘤中的临床应用价值[J]. 临床血液学杂志, 2021, 34(1): 18-23.   doi: 10.13201/j.issn.1004-2806.2021.01.005
Sun Y, Xu H, Guo ZQ, et al.  Explore the clinical value of 18F-FDG PET/CT SUVmax, SUVsum and pathological Ki67 expression in non-Hodgkin's lymphoma[J]. J Clin Hematol, 2021, 34(1): 18-23.   doi: 10.13201/j.issn.1004-2806.2021.01.005
[11] Adams HJA, de Klerk JMH, Fijnheer R, et al.  Prognostic value of anemia and C-reactive protein levels in diffuse large B-cell lymphoma[J]. Clin Lymphoma Myeloma Leuk, 2015, 15(11): 671-679.   doi: 10.1016/j.clml.2015.07.639